These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 29493395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
    Opitz DL, Tyler KF.
    Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761
    [Abstract] [Full Text] [Related]

  • 3. Oral azithromycin for treatment of posterior blepharitis.
    Igami TZ, Holzchuh R, Osaki TH, Santo RM, Kara-Jose N, Hida RY.
    Cornea; 2011 Oct; 30(10):1145-9. PubMed ID: 21849891
    [Abstract] [Full Text] [Related]

  • 4. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
    Haque RM, Torkildsen GL, Brubaker K, Zink RC, Kowalski RP, Mah FS, Pflugfelder SC.
    Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis.
    Luchs J.
    Adv Ther; 2008 Sep; 25(9):858-70. PubMed ID: 18781287
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
    Torkildsen GL, Cockrum P, Meier E, Hammonds WM, Silverstein B, Silverstein S.
    Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term, Low-Dose Oral Azithromycin Treatment for Chronic Severe Bilateral Blepharokeratoconjunctivitis in Pediatric Patients.
    Sari ES, Ozmen AT, Yildiz M, Akova B, Baykara M, Hasanova S.
    J Pediatr Ophthalmol Strabismus; 2024 Jan; 61(5):358-364. PubMed ID: 38815106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Role of Topical Azithromycin in the Treatment of Meibomian Gland Dysfunction.
    Ciloglu E, Özcan AA, Incekalan T, Unal F.
    Cornea; 2020 Mar; 39(3):321-324. PubMed ID: 31842036
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ, Bickle KM, Zink RC, Schiewe MD, Haque RM, Nichols KK.
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.